Try our Advanced Search for more refined results

September 11, 2009

In Re: Celexa and Lexapro Marketing and Sales Practices Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 29, 2018

    Forest Beats Final Cases In Celexa, Lexapro MDL

    Forest Laboratories Inc. prevailed on Monday against claims by a health and benefit fund and a pair of mothers that it fraudulently promoted Celexa and Lexapro for pediatric depression, putting long-running Massachusetts multidistrict litigation against the company to rest.

13 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!